Estrella Immunopharma ESLA
NASDAQ ESLA
$0.47 -0.33 (-41.38%)
As of: Nov 12, 2026 · 12:19 PM EST

Estrella Immunopharma (ESLA) Cash from Investing Activities (2021 - 2023)

Updated

Estrella Immunopharma (ESLA) posted Cash from Investing Activities of $4.96 million for FY2024, compared with -$273,066 in FY2023.

Analysis

Estrella Immunopharma (ESLA) Cash from Investing Activities (2021 - 2023) Analysis & Trends

Since FY2021, Estrella Immunopharma has reported Cash from Investing Activities for 4 years.

  • Annual Cash from Investing Activities has run from a low of -$45.19 million in FY2021 to a high of $36.17 million in FY2022 over five years.
  • Business Quant data shows ESLA's Cash from Investing Activities at -$273,066 in FY2023, $36.17 million in FY2022 and -$45.19 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -8.30 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -2.71 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -10.22 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -1.32 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.89 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -649.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -244.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -2.03 Bn
10 Estrella Immunopharma 32.66 Mn 27.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 5.07 Mn
Sep 30, 2023 -112,298.00
Mar 31, 2023 77,773.00
Sep 30, 2021 -42.00 Mn
API Access

Estrella Immunopharma Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ESLA&period=max&api_key=YOUR_API_KEY